Exchange: NYSE·Updated 06:46 PM EDT
RVTY logo

RVTYRevvity Inc.

$111.26
$0.05
(0.04%)
Today
Closed $111.26
$0.26
(0.23%)
After Hours
EarningsJul 27
Mkt Cap$12.41B
Vol2.49M
News
all
press releases
Revvity Launches Signals AI to Advance Scientific R&D Workflows
RVTY expands AI capabilities in Signals software with Signals AI, designed to help scientists turn connected R&D data into actionable insights.
Zacks
News Placeholder
More News
News Placeholder
Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D
Revvity, Inc. (NYSE: RVTY) announced the continued evolution of artificial intelligence across its Revvity Signals software business with new and expanding AI capabilities. Built natively into the Signals One platform, new capabilities from Signals AI help scientists transform connected R&D data...
Business Wire
News Placeholder
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report?
Revvity (RVTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay
Revvity gains FDA clearance for IDS' Total Testosterone assay, expanding its automated endocrine testing platform for reproductive diagnostics.
Zacks
News Placeholder
JPMorgan Chase & Co. Has Lowered Expectations for Revvity (NYSE:RVTY) Stock Price
JPMorgan Chase & Co. decreased their target price on shares of Revvity from $96.00 to $90.00 and set a "neutral" rating on the stock in a report on Wednesday...
MarketBeat
News Placeholder
TD Cowen Forecasts Strong Price Appreciation for Revvity (NYSE:RVTY) Stock
TD Cowen raised their target price on Revvity from $115.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday...
MarketBeat
News Placeholder
RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution
Revvity beat Q1 EPS and revenue estimates as 3% organic growth and portfolio execution offset margin pressure and China ImmunoDx divest plans.
Zacks
News Placeholder
Revvity (NYSE:RVTY) Posts Earnings Results, Beats Expectations By $0.04 EPS
Revvity (NYSE:RVTY - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $1.02 by $0.04. The...
MarketBeat
News Placeholder
Compared to Estimates, Revvity (RVTY) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Revvity (RVTY) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
News Placeholder
Revvity Q1 Earnings Call Highlights
Revvity (NYSE:RVTY) reported first-quarter 2026 results that came in ahead of its expectations and outlined a planned divestiture of its immunodiagnostics business in China, a move management said will sharpen the company's focus and improve growth and profitability metrics going forward. First-qua...
MarketBeat
<
1
2
...
>